https://www.selleckchem.com/pr....oducts/myf-01-37.htm
74-0.96]), and cardiac glycoside therapy (HR 0.69 [0.56-0.84]). LTPA was non-linearly related to a delayed initiation of glucose-lowering, antihypertensive, statin, fibrate, antiplatelet, antianginal, and cardiac glycoside therapy (minimum risk 180-360 metabolic equivalents of task-min/day). Both combined were synergistically associated with a decreased onset of glucose-lowering drugs (p-interaction = 0.04), antihypertensive drugs (p-interaction less then 0.001), vitamin K antagonists (p-interaction = 0.04), and cardiac glycosides (p-
כמו
תגובה
לַחֲלוֹק
